Across healthcare, providers are rapidly deploying tools such as ambient clinical documentation, while payers are adopting AI-powered agents for a growing range of operational and administrative use ...
Zacks Investment Research on MSN
BSX vs. RMD: Which medical device stock is the stronger play now?
Boston Scientific BSX and Resmed RMD are two major players in the global medical devices market, with market capitalizations of $142.4 billion and $35.72 billion, respectively. Marlborough, MA-based ...
Artificial Intelligence (AI) technologies are no longer a futuristic concept — they are practical tools that organizations of ...
Cancer is no longer considered untreatable, yet improving the accuracy and timeliness of diagnostics and treatment remains ...
AI chatbot achieves high accuracy in performing clinical patient diagnostic interviews for common mental health disorders.
Where healthcare is really using AI in 2025 shows focus on ambient speech, revenue cycle, and administrative tasks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback